{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:23:39Z","timestamp":1792193019354,"version":"4.4.0"},"reference-count":154,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,28]]},"DOI":"10.5334\/tohm.747","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T09:00:01Z","timestamp":1679994001000},"source":"Crossref","is-referenced-by-count":30,"title":["Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches"],"prefix":"10.5334","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-2751","authenticated-orcid":false,"given":"Anhar","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"18","key":"key20250825114838_B1","article-title":"Episodic Ataxias: Faux or Real?","volume":"21","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key20250825114838_B2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14802\/jmd.16028","article-title":"Episodic Ataxias: Clinical and Genetic Features","volume":"9","year":"2016","journal-title":"J Mov Disord"},{"issue":"8","key":"key20250825114838_B3","article-title":"Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity","volume":"21","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"key20250825114838_B4","article-title":"Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias","volume":"21","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20250825114838_B5","first-page":"317","article-title":"New insights into the pathogenesis and therapeutics of episodic ataxia type 1","volume":"9","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"Pt 4","key":"key20250825114838_B6","first-page":"1009","article-title":"Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation","volume":"137","year":"2014","journal-title":"Brain"},{"key":"key20250825114838_B7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-444-64189-2.00013-5","article-title":"Episodic ataxias","volume":"155","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"key20250825114838_B8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/jnnp-2012-304131","article-title":"Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1","volume":"84","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"key20250825114838_B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10048-015-0460-2","article-title":"Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations","volume":"17","year":"2016","journal-title":"Neurogenetics"},{"issue":"8","key":"key20250825114838_B10","article-title":"Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches","volume":"21","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20250825114838_B11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mcn.2017.06.006","article-title":"A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions","volume":"83","year":"2017","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"key20250825114838_B12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2004-817921","article-title":"Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy","volume":"35","year":"2004","journal-title":"Neuropediatrics"},{"issue":"4","key":"key20250825114838_B13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10048-016-0486-0","article-title":"A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia","volume":"17","year":"2016","journal-title":"Neurogenetics"},{"issue":"3","key":"key20250825114838_B14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mus.20904","article-title":"Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea","volume":"37","year":"2008","journal-title":"Muscle Nerve"},{"issue":"8","key":"key20250825114838_B15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/ajmg.a.38840","article-title":"De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants","volume":"176","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"10","key":"key20250825114838_B16","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1002\/mgg3.1434","article-title":"Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders","volume":"8","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"key20250825114838_B17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.0b013e3181ea9ee3","article-title":"Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins","volume":"75","year":"2010","journal-title":"Neurology"},{"issue":"8","key":"key20250825114838_B18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/acn3.597","article-title":"Paroxysmal motor disorders: expanding phenotypes lead to coalescing genotypes","volume":"5","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"key20250825114838_B19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.119.264507","article-title":"Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine","volume":"373","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"key20250825114838_B20","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1523\/JNEUROSCI.1143-18.2019","article-title":"Epilepsy Gene Therapy Using an Engineered Potassium Channel","volume":"39","year":"2019","journal-title":"J Neurosci"},{"issue":"3","key":"key20250825114838_B21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mayocp.2015.01.001","article-title":"Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1","volume":"90","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"23","key":"key20250825114838_B22","first-page":"e239","article-title":"Pearls & Oy-sters: Episodic ataxia type 2: Case report and review of the literature","volume":"86","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"key20250825114838_B23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.WNL.0000101675.61074.50","article-title":"Clinical spectrum of episodic ataxia type 2","volume":"62","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"key20250825114838_B24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/01.wnl.0000176069.64200.28","article-title":"Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A","volume":"65","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"key20250825114838_B25","doi-asserted-by":"crossref","first-page":"e56362","DOI":"10.1371\/journal.pone.0056362","article-title":"Identification of a novel nonsense mutation p.Tyr1957Ter of CACNA1A in a Chinese family with episodic ataxia 2","volume":"8","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"key20250825114838_B26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpn.2014.10.005","article-title":"Novel frameshift mutation in the CACNA1A gene causing a mixed phenotype of episodic ataxia and familiar hemiplegic migraine","volume":"19","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"key20250825114838_B27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00415-014-7310-2","article-title":"Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature","volume":"261","year":"2014","journal-title":"J Neurol"},{"issue":"3","key":"key20250825114838_B28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","article-title":"Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4","volume":"87","year":"1996","journal-title":"Cell"},{"issue":"2","key":"key20250825114838_B29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrneurol.2011.228","article-title":"Neuronal P\/Q-type calcium channel dysfunction in inherited disorders of the CNS","volume":"8","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"key20250825114838_B30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/jnnp.2008.159103","article-title":"Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhood","volume":"80","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"key20250825114838_B31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejpn.2016.11.005","article-title":"Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia","volume":"21","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"key20250825114838_B32","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.57.10.1843","article-title":"Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission","volume":"57","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"key20250825114838_B33","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s00415-021-10856-4","article-title":"Vestibular impairments in episodic ataxia type 2","volume":"269","year":"2022","journal-title":"J Neurol"},{"key":"key20250825114838_B34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2017.07.040","article-title":"Slowed abduction during smooth pursuit eye movement in episodic ataxia type 2 with a novel CACNA1A mutation","volume":"381","year":"2017","journal-title":"J Neurol Sci"},{"issue":"12","key":"key20250825114838_B35","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1007\/s00415-013-7099-4","article-title":"Novel CACNA1A mutation(s) associated with slow saccade velocities","volume":"260","year":"2013","journal-title":"J Neurol"},{"issue":"8","key":"key20250825114838_B36","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10072-015-2157-6","article-title":"Exercise-induced downbeat nystagmus in a Korean family with a nonsense mutation in CACNA1A","volume":"36","year":"2015","journal-title":"Neurol Sci"},{"issue":"3","key":"key20250825114838_B37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejpn.2014.12.018","article-title":"Paroxysmal tonic upward gaze as a presentation of de-novo mutations in CACNA1A","volume":"19","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"key20250825114838_B38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/dmcn.13033","article-title":"Eye movement disorders are an early manifestation of CACNA1A mutations in children","volume":"58","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"key20250825114838_B39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0883073816636226","article-title":"The Genetics of Benign Paroxysmal Torticollis of Infancy: Is There an Association With Mutations in the CACNA1A Gene?","volume":"31","year":"2016","journal-title":"J Child Neurol"},{"issue":"6","key":"key20250825114838_B40","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s00415-021-10897-9","article-title":"The complexities of CACNA1A in clinical neurogenetics","volume":"269","year":"2022","journal-title":"J Neurol"},{"issue":"11","key":"key20250825114838_B41","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/ejhg.2015.21","article-title":"CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms","volume":"23","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"key20250825114838_B42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejpn.2020.10.004","article-title":"Clinical phenotypes of infantile onset CACNA1A-related disorder","volume":"30","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"key20250825114838_B43","article-title":"Association of A Novel Splice Site Mutation in P\/Q-Type Calcium Channels with Childhood Epilepsy and Late-Onset Slowly Progressive Non-Episodic Cerebellar Ataxia","volume":"21","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"key20250825114838_B44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/ene.13765","article-title":"The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature","volume":"26","year":"2019","journal-title":"Eur J Neurol"},{"issue":"3","key":"key20250825114838_B45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dmcn.14261","article-title":"Cognitive impairment in children with CACNA1A mutations","volume":"62","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"key20250825114838_B46","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00415-021-10415-x","article-title":"The electrophysiological footprint of CACNA1A disorders","volume":"268","year":"2021","journal-title":"J Neurol"},{"issue":"6","key":"key20250825114838_B47","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00415-021-10878-y","article-title":"Instrumented gait analysis defines the walking signature of CACNA1A disorders","volume":"269","year":"2022","journal-title":"J Neurol"},{"issue":"10","key":"key20250825114838_B48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.braindev.2019.06.006","article-title":"Single-fiber electromyography-based diagnosis of CACNA1A mutation in children: A potential role of the electrodiagnosis in the era of whole exome sequencing","volume":"41","year":"2019","journal-title":"Brain Dev"},{"key":"key20250825114838_B49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2016.10.029","article-title":"Episodic ataxia and SCA6 within the same family due to the D302N CACNA1A gene mutation","volume":"371","year":"2016","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"key20250825114838_B50","first-page":"181","article-title":"A novel pathogenic CACNA1A variant causing episodic ataxia type 2 (EA2) spectrum phenotype in four family members and a novel combined therapy","volume":"267","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"key20250825114838_B51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12883-020-01704-5","article-title":"Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant","volume":"20","year":"2020","journal-title":"BMC Neurol"},{"issue":"6","key":"key20250825114838_B52","doi-asserted-by":"crossref","first-page":"103530","DOI":"10.1016\/j.ejmg.2018.08.011","article-title":"Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant","volume":"62","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"4","key":"key20250825114838_B53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pediatrneurol.2014.07.008","article-title":"Phenotypic variability in a four generation family with a p.Thr666Met CACNA1A gene mutation","volume":"51","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"9","key":"key20250825114838_B54","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s10072-013-1298-8","article-title":"Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2","volume":"34","year":"2013","journal-title":"Neurol Sci"},{"issue":"6","key":"key20250825114838_B55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.12809\/hkmj198306","article-title":"Differentiating episodic ataxia type 2 from migraine: a case report","volume":"26","year":"2020","journal-title":"Hong Kong Med J"},{"issue":"2","key":"key20250825114838_B56","article-title":"Episodic Ataxia Misdiagnosed as Anxiety Disorder","volume":"23","year":"2021","journal-title":"Prim Care Companion CNS Disord"},{"issue":"4","key":"key20250825114838_B57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12311-018-0931-8","article-title":"A Novel Frameshift CACNA1A Mutation Causing Episodic Ataxia Type 2","volume":"17","year":"2018","journal-title":"Cerebellum"},{"issue":"5","key":"key20250825114838_B58","first-page":"533","article-title":"Acetazolamide-responsive ataxia","volume":"32","year":"2012","journal-title":"Semin Neurol"},{"issue":"9","key":"key20250825114838_B59","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/01.WNL.0000125691.74109.53","article-title":"Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine","volume":"62","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"key20250825114838_B60","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00415-012-6764-3","article-title":"Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study","volume":"260","year":"2013","journal-title":"J Neurol"},{"issue":"4","key":"key20250825114838_B61","first-page":"e438","article-title":"Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial","volume":"11","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"8","key":"key20250825114838_B62","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1007\/s10072-022-06144-2","article-title":"The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2","volume":"43","year":"2022","journal-title":"Neurol Sci"},{"issue":"1","key":"key20250825114838_B63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/CPJ.0000000000000321","article-title":"Aminopyridines for the treatment of neurologic disorders","volume":"7","year":"2017","journal-title":"Neurol Clin Pract"},{"issue":"9","key":"key20250825114838_B64","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s10072-021-05368-y","article-title":"Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports","volume":"42","year":"2021","journal-title":"Neurol Sci"},{"issue":"7","key":"key20250825114838_B65","first-page":"e43","article-title":"Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation","volume":"24","year":"2017","journal-title":"Eur J Neurol"},{"issue":"1","key":"key20250825114838_B66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12883-019-1491-3","article-title":"A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine","volume":"19","year":"2019","journal-title":"BMC Neurol"},{"issue":"8","key":"key20250825114838_B67","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.57.8.1499","article-title":"An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus","volume":"57","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"key20250825114838_B68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/01.wnl.0000167186.05465.7c","article-title":"A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia","volume":"65","year":"2005","journal-title":"Neurology"},{"key":"key20250825114838_B69","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archneur.1963.00460050021002","article-title":"Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations","volume":"8","year":"1963","journal-title":"Arch Neurol"},{"issue":"5","key":"key20250825114838_B70","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.28491","article-title":"Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible Mechanism","volume":"36","year":"2021","journal-title":"Mov Disord"},{"issue":"4","key":"key20250825114838_B71","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archneur.1996.00550040074016","article-title":"Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias","volume":"53","year":"1996","journal-title":"Arch Neurol"},{"issue":"3","key":"key20250825114838_B72","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/nan.12262","article-title":"Neuropathology in a case of episodic ataxia type 4","volume":"42","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"key20250825114838_B73","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/302909","article-title":"Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia","volume":"66","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"1","key":"key20250825114838_B74","doi-asserted-by":"crossref","first-page":"13855","DOI":"10.1038\/s41598-017-14254-7","article-title":"Genetic Variants Associated with Episodic Ataxia in Korea","volume":"7","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"key20250825114838_B75","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00415-008-0844-4","article-title":"Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneity","volume":"255","year":"2008","journal-title":"J Neurol"},{"key":"key20250825114838_B76","doi-asserted-by":"crossref","first-page":"919996","DOI":"10.3389\/fped.2022.919996","article-title":"Whole-Exome Sequencing Identifies Novel SCN1A and CACNB4 Genes Mutations in the Cohort of Saudi Patients With Epilepsy","volume":"10","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"key20250825114838_B77","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000172638.58172.5a","article-title":"Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures","volume":"65","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"key20250825114838_B78","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/humu.24089","article-title":"Functional consequences of SLC1A3 mutations associated with episodic ataxia 6","volume":"41","year":"2020","journal-title":"Hum Mutat"},{"issue":"3","key":"key20250825114838_B79","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/jhg.2016.137","article-title":"Late-onset episodic ataxia associated with SLC1A3 mutation","volume":"62","year":"2017","journal-title":"J Hum Genet"},{"issue":"1","key":"key20250825114838_B80","first-page":"97","article-title":"Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake","volume":"66","year":"2009","journal-title":"Arch Neurol"},{"issue":"Pt 2","key":"key20250825114838_B81","first-page":"276","article-title":"Exome sequencing in undiagnosed inherited and sporadic ataxias","volume":"138","year":"2015","journal-title":"Brain"},{"issue":"2","key":"key20250825114838_B82","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s10038-017-0365-z","article-title":"A novel mutation in SLC1A3 causes episodic ataxia","volume":"63","year":"2018","journal-title":"J Hum Genet"},{"issue":"Pt 11","key":"key20250825114838_B83","first-page":"3416","article-title":"A point mutation associated with episodic ataxia 6 increases glutamate transporter anion currents","volume":"135","year":"2012","journal-title":"Brain"},{"issue":"1","key":"key20250825114838_B84","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1038\/s41598-017-14176-4","article-title":"Impaired K(+) binding to glial glutamate transporter EAAT1 in migraine","volume":"7","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"key20250825114838_B85","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.64.5.749","article-title":"A new episodic ataxia syndrome with linkage to chromosome 19q13","volume":"64","year":"2007","journal-title":"Arch Neurol"},{"issue":"4","key":"key20250825114838_B86","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ejhg.2013.173","article-title":"A novel locus for episodic ataxia:UBR4 the likely candidate","volume":"22","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"key20250825114838_B87","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/jnnp.2008.150615","article-title":"Late onset hereditary episodic ataxia","volume":"80","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"key20250825114838_B88","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s00415-021-10712-5","article-title":"Episodic ataxia and severe infantile phenotype in spinocerebellar ataxia type 14: expansion of the phenotype and novel mutations","volume":"269","year":"2022","journal-title":"J Neurol"},{"key":"key20250825114838_B89","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5334\/tohm.436","article-title":"Spinocerebellar Ataxia 27: A Review and Characterization of an Evolving Phenotype","volume":"8","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"4","key":"key20250825114838_B90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/acn3.51005","article-title":"FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9","volume":"7","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"key20250825114838_B91","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpn.2013.10.006","article-title":"A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene","volume":"18","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"key20250825114838_B92","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12311-018-0997-3","article-title":"Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene","volume":"18","year":"2019","journal-title":"Cerebellum"},{"issue":"2","key":"key20250825114838_B93","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000515974","article-title":"Episodic Vestibulocerebellar Ataxia Associated with a CACNA1G Missense Variant","volume":"13","year":"2021","journal-title":"Case Rep Neurol"},{"issue":"3","key":"key20250825114838_B94","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4103\/0028-3886.232295","article-title":"Episodic ataxia in a child with senataxin mutation","volume":"66","year":"2018","journal-title":"Neurol India"},{"key":"key20250825114838_B95","doi-asserted-by":"crossref","first-page":"637890","DOI":"10.3389\/fneur.2021.637890","article-title":"ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum","volume":"12","year":"2021","journal-title":"Front Neurol"},{"key":"key20250825114838_B96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pediatrneurol.2016.02.010","article-title":"The Genetic Homogeneity of CAPOS Syndrome: Four New Patients With the c.2452G>A (p.Glu818Lys) Mutation in the ATP1A3 Gene","volume":"59","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"14","key":"key20250825114838_B97","first-page":"e1511","article-title":"The Phenotypic Continuum of ATP1A3-Related Disorders","volume":"99","year":"2022","journal-title":"Neurology"},{"key":"key20250825114838_B98","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2018.06.010","article-title":"The glucose transporter type 1 (Glut1) syndromes","volume":"91","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"1","key":"key20250825114838_B99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/NRL.0000000000000168","article-title":"Acetazolamide-responsive Episodic Ataxia Without Baseline Deficits or Seizures Secondary to GLUT1 Deficiency: A Case Report and Review of the Literature","volume":"23","year":"2018","journal-title":"Neurologist"},{"issue":"Pt 12","key":"key20250825114838_B100","first-page":"3567","article-title":"The clinical and genetic heterogeneity of paroxysmal dyskinesias","volume":"138","year":"2015","journal-title":"Brain"},{"issue":"2","key":"key20250825114838_B101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neurol.2013.09.005","article-title":"GLUT1 deficiency syndrome: an update","volume":"170","year":"2014","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"key20250825114838_B102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pediatrneurol.2013.09.002","article-title":"A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia","volume":"50","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"Pt 3","key":"key20250825114838_B103","first-page":"655","article-title":"Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder","volume":"133","year":"2010","journal-title":"Brain"},{"issue":"5","key":"key20250825114838_B104","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/dmcn.12096","article-title":"Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study","volume":"55","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"key20250825114838_B105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mds.27140","article-title":"Treatable inherited rare movement disorders","volume":"33","year":"2018","journal-title":"Mov Disord"},{"issue":"19","key":"key20250825114838_B106","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0000000000003309","article-title":"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy","volume":"87","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"key20250825114838_B107","article-title":"Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders","volume":"22","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key20250825114838_B108","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejpn.2019.03.001","article-title":"Clinical and genetic spectrum of SCN2A-associated episodic ataxia","volume":"23","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"key20250825114838_B109","article-title":"Whole-Exome Sequencing Implicates SCN2A in Episodic Ataxia, but Multiple Ion Channel Variants May Contribute to Phenotypic Complexity","volume":"19","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"Suppl 3","key":"key20250825114838_B110","first-page":"S59","article-title":"Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond","volume":"60","year":"2019","journal-title":"Epilepsia"},{"issue":"2","key":"key20250825114838_B111","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00415-015-7984-0","article-title":"Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia","volume":"263","year":"2016","journal-title":"J Neurol"},{"issue":"3","key":"key20250825114838_B112","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ajmg.a.62595","article-title":"Further delineation of phenotypic spectrum of SCN2A-related disorder","volume":"188","year":"2022","journal-title":"Am J Med Genet A"},{"issue":"1","key":"key20250825114838_B113","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.braindev.2020.08.009","article-title":"Dominant SCN2A mutation with variable phenotype in two generations","volume":"43","year":"2021","journal-title":"Brain Dev"},{"issue":"6","key":"key20250825114838_B114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0038-1668141","article-title":"Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development","volume":"49","year":"2018","journal-title":"Neuropediatrics"},{"issue":"5","key":"key20250825114838_B115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejpn.2016.05.020","article-title":"Episodic ataxia associated with a de novo SCN2A mutation","volume":"20","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"key20250825114838_B116","doi-asserted-by":"crossref","first-page":"104450","DOI":"10.1016\/j.ejmg.2022.104450","article-title":"Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy","volume":"65","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"1","key":"key20250825114838_B117","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajhg.2011.12.003","article-title":"PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome","volume":"90","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"12","key":"key20250825114838_B118","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ng.1008","article-title":"Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia","volume":"43","year":"2011","journal-title":"Nat Genet"},{"issue":"Pt 12","key":"key20250825114838_B119","first-page":"3493","article-title":"Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias","volume":"134","year":"2011","journal-title":"Brain"},{"issue":"9","key":"key20250825114838_B120","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/mds.25933","article-title":"Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification","volume":"29","year":"2014","journal-title":"Mov Disord"},{"issue":"21","key":"key20250825114838_B121","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1212\/WNL.0b013e3182752c5a","article-title":"PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine","volume":"79","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"key20250825114838_B122","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.10.021","article-title":"Acute-Onset Ataxia and Transient Cerebellar Diffusion Restriction Associated with a PRRT2 Mutation","volume":"28","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"key20250825114838_B123","first-page":"2929","article-title":"Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia","volume":"143","year":"2020","journal-title":"Brain"},{"issue":"10","key":"key20250825114838_B124","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tins.2016.08.005","article-title":"PRRT2: from Paroxysmal Disorders to Regulation of Synaptic Function","volume":"39","year":"2016","journal-title":"Trends Neurosci"},{"issue":"7","key":"key20250825114838_B125","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/jnnp-2014-309025","article-title":"Severe phenotypic spectrum of biallelic mutations in PRRT2 gene","volume":"86","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7367","key":"key20250825114838_B126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature10423","article-title":"Deep sequencing reveals 50 novel genes for recessive cognitive disorders","volume":"478","year":"2011","journal-title":"Nature"},{"issue":"12","key":"key20250825114838_B127","first-page":"e196","article-title":"Homozygous c.649dupC mutation in PRRT2 worsens the BFIS\/PKD phenotype with mental retardation, episodic ataxia, and absences","volume":"53","year":"2012","journal-title":"Epilepsia"},{"issue":"5","key":"key20250825114838_B128","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1055\/s-0039-1688410","article-title":"Infantile-Onset Paroxysmal Movement Disorder and Episodic Ataxia Associated with a TBC1D24 Mutation","volume":"50","year":"2019","journal-title":"Neuropediatrics"},{"issue":"5","key":"key20250825114838_B129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12098-021-04068-x","article-title":"Pyruvate Dehydrogenase Complex Deficiency Due to PDHA1 Mutation-A Rare Treatable Cause for Episodic Ataxia in Children","volume":"89","year":"2022","journal-title":"Indian J Pediatr"},{"issue":"6","key":"key20250825114838_B130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/acn3.51074","article-title":"Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2","volume":"7","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"key20250825114838_B131","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/B978-0-444-52910-7.00043-X","article-title":"Ataxia","volume":"112","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"key20250825114838_B132","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/dmcn.12081","article-title":"The epidemiology of intermittent and chronic ataxia in children in Manitoba, Canada","volume":"55","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"23","key":"key20250825114838_B133","first-page":"e2727","article-title":"Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome","volume":"92","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"key20250825114838_B134","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1212\/WNL.0b013e31827dec0f","article-title":"Harry Lee Parker and paroxysmal dysarthria and ataxia","volume":"80","year":"2013","journal-title":"Neurology"},{"issue":"1\u20132","key":"key20250825114838_B135","first-page":"85","article-title":"Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff\u2019s-like encephalitis","volume":"341","year":"2014","journal-title":"J Neurol Sci"},{"issue":"3","key":"key20250825114838_B136","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0038-1660851","article-title":"Autoimmune Movement Disorders","volume":"38","year":"2018","journal-title":"Semin Neurol"},{"issue":"4","key":"key20250825114838_B137","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10545-014-9712-9","article-title":"Defects of thiamine transport and metabolism","volume":"37","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"key20250825114838_B138","article-title":"Hypomorphic citrullinaemia due to mutated ASS1 with episodic ataxia","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"2","key":"key20250825114838_B139","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1212\/NXI.0000000000000536","article-title":"Episodic ataxia in CASPR2 autoimmunity","volume":"6","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"key20250825114838_B140","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1212\/NXI.0000000000000371","article-title":"Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis","volume":"4","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"key20250825114838_B141","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/epi.17164","article-title":"CASPR2-IgG-associated autoimmune seizures","volume":"63","year":"2022","journal-title":"Epilepsia"},{"key":"key20250825114838_B142","doi-asserted-by":"crossref","first-page":"577327","DOI":"10.1016\/j.jneuroim.2020.577327","article-title":"Paroxysmal dysarthria-ataxia syndrome: Literature review on MRI findings and report of a peculiar case with clinically isolated syndrome coexisting with anti-N-methyl-d-aspartate receptor antibodies","volume":"347","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"9","key":"key20250825114838_B143","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1469-8749.2012.04221.x","article-title":"An unusual presentation of anti-Hu-associated paraneoplastic limbic encephalitis","volume":"54","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"key20250825114838_B144","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2020.09.009","article-title":"Ataxia and tolerance after thalamic deep brain stimulation for essential tremor","volume":"80","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"key20250825114838_B145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/dmcn.13744","article-title":"Phenotypes, genotypes, and the management of paroxysmal movement disorders","volume":"60","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"key20250825114838_B146","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ene.12104","article-title":"PRRT2 mutations and paroxysmal disorders","volume":"20","year":"2013","journal-title":"Eur J Neurol"},{"issue":"4","key":"key20250825114838_B147","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10072-019-04190-x","article-title":"Epilepsy and brain channelopathies from infancy to adulthood","volume":"41","year":"2020","journal-title":"Neurol Sci"},{"issue":"4","key":"key20250825114838_B148","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cge.14180","article-title":"Clinical and genetic characterization of CACNA1A-related disease","volume":"102","year":"2022","journal-title":"Clin Genet"},{"issue":"4","key":"key20250825114838_B149","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10072-019-04113-w","article-title":"Identification of common genetic markers of paroxysmal neurological disorders using a network analysis approach","volume":"41","year":"2020","journal-title":"Neurol Sci"},{"key":"key20250825114838_B150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.parkreldis.2019.02.021","article-title":"Paroxysmal movement disorders: Recent advances and proposal of a classification system","volume":"59","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 2","key":"key20250825114838_B151","first-page":"313","article-title":"Extending the clinical spectrum of pain channelopathies","volume":"135","year":"2012","journal-title":"Brain"},{"issue":"3","key":"key20250825114838_B152","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/mds.26901","article-title":"The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies","volume":"32","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"key20250825114838_B153","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(14)70220-0","article-title":"Migraine pathophysiology: lessons from mouse models and human genetics","volume":"14","year":"2015","journal-title":"Lancet Neurol"},{"issue":"7","key":"key20250825114838_B154","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","year":"2013","journal-title":"Mov Disord"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/747\/68ac4d84a87f8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:05:50Z","timestamp":1761552350000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.747\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,28]]}},"alternative-id":["10.5334\/tohm.747"],"URL":"https:\/\/doi.org\/10.5334\/tohm.747","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"9"}}